Stay updated with breaking news from Lab Gene. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cipla Limited on Thursday announced the commercialisation of a polymerase chain reaction (RT-PCR) test kit 'ViraGen for COVID-19 in India, in partnership with Ubio Biotechnology Systems Pvt. Ltd.ViraGen is Cipla's third offering in the Covid-19 ...
ViraGen used for qualitative detection of SARS-CoV-2 will be manufactured by Ubio Biotechnology Systems. Shares of the country's leading drug maker - Cipla - rose as much as 2.63 per cent to hit an intraday high of Rs 927.85 after the company launched Coronavirus detections test kit. "Cipla announced the commercialization of a polymerase chain reaction (RT-PCR) test kit 'ViraGen' for COVID-19 in India, in partnership with Ubio Biotechnology Systems Pvt. Ltd. ViraGen is Cipla's third offering in the Covid-19 testing segment. Cipla already has partnerships for antibody detection kit and antigen...
Cipla launches COVID-19 real-time test kit 'ViraGen'; to be sold from May 25 'ViraGen' is the third COVID-19 testing kit by Cipla as the pharma major already has partnerships for antibody detection kit and antigen test kits BusinessToday.In | May 20, 2021 | Updated 10:30 IST Pharma major Cipla has teamed up with Ubio Technologies Biotechnology Systems to launch a polymerase chain reaction (RT-PCR) COVID-19 test kit 'ViraGen' in India. Cipla will use its distribution network to market and distribute this test kit from May 25, 2021. 'ViraGen' is the third COVID-19 testing kit by Cipla as the ...